Physician profile
Gregory S Smith
NPI 1861582934
$1,066.65
in general payments reported to CMS, 2019-2025
17 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $111 · 2021: $146 · 2022: $190 · 2023: $138 · 2024: $205 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $620.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $203.72 | 2020-2024 | Epclusa |
| Novo Nordisk INC | $181.54 | 2021-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $129.08 | 2022-2025 | Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $78.78 | 2024-2025 | Farxiga, Airsupra |
| Regeneron Healthcare Solutions, INC. | $74.40 | 2024 | Evkeeza |
| Exact Sciences Corporation | $63.39 | 2023-2024 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $48.88 | 2024-2025 | Zoryve |
| Pfizer INC. | $47.45 | 2020-2024 | |
| Baxter Healthcare | $43.88 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.29 | 2021-2022 | |
| Itamar Medical INC | $36.17 | 2021 | |
| Almatica Pharma LLC | $23.25 | 2025 | Loreev Xr |
| Shield Therapeutics INC | $21.90 | 2025 | |
| Novartis Pharmaceuticals Corporation | $20.77 | 2020 | |
| Xeris Pharmaceuticals, INC. | $18.90 | 2025 | Gvoke Hypopen |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $16.67 | 2024 | |
| Glaxosmithkline, LLC. | $14.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.